Trials / Conditions / Stage IV Anal Cancer AJCC v8
Stage IV Anal Cancer AJCC v8
4 registered clinical trials studyying Stage IV Anal Cancer AJCC v8 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients NCT04444921 | National Cancer Institute (NCI) | Phase 3 |
| Recruiting | Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893 | University of California, San Francisco | N/A |
| Terminated | DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating P NCT03439085 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer NCT02314169 | National Cancer Institute (NCI) | Phase 2 |